ACADIA Pharmaceuticals Inc Cash Flow-to-Debt Ratio
ACADIA Pharmaceuticals Inc cash flow-to-debt ratio. ACADIA Pharmaceuticals Inc (ACAD) has a Cash Flow-to-Debt Ratio of 0.31x as of June 2026, meaning its operating cash flow of $134.76 Million could theoretically repay 0% of its total liabilities ($436.29 Million) in one year. Check ACADIA Pharmaceuticals Inc (ACAD) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ACADIA Pharmaceuticals Inc (2002–2025)
Cash flow-to-debt ratio of ACADIA Pharmaceuticals Inc from 2002 to 2025. Historical debt coverage capacity for ACADIA Pharmaceuticals Inc across 24 annual periods. Check total reinvestment intensity of ACADIA Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
ACADIA Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2002–2025)
ACADIA Pharmaceuticals Inc cash flow-to-debt ratio by year from 2002 to 2025. Year-by-year debt coverage analysis for ACADIA Pharmaceuticals Inc. For the full cash flow conversion analysis, see how efficiently does ACADIA Pharmaceuticals Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | $109.84 Million | $336.81 Million | ▼ -5.9% |
| 2024 | 0.35x | $157.72 Million | $454.96 Million | ▲ +558.4% |
| 2023 | 0.05x | $16.70 Million | $317.20 Million | ▲ +108.7% |
| 2022 | -0.61x | $-114.03 Million | $187.40 Million | ▲ +22.9% |
| 2021 | -0.79x | $-125.66 Million | $159.23 Million | ▲ +9.8% |
| 2020 | -0.88x | $-136.17 Million | $155.61 Million | ▲ +51.3% |
| 2019 | -1.80x | $-151.13 Million | $84.05 Million | ▲ +34.4% |
| 2018 | -2.74x | $-167.47 Million | $61.12 Million | ▲ +38.1% |
| 2017 | -4.43x | $-217.86 Million | $49.22 Million | ▲ +10.1% |
| 2016 | -4.92x | $-210.41 Million | $42.74 Million | ▲ +10.5% |
| 2015 | -5.50x | $-121.80 Million | $22.13 Million | ▼ -32.3% |
| 2014 | -4.16x | $-66.43 Million | $15.97 Million | ▲ +8.5% |
| 2013 | -4.55x | $-31.77 Million | $6.99 Million | ▼ -396.2% |
| 2012 | -0.92x | $-21.63 Million | $23.61 Million | ▲ +59.7% |
| 2011 | -2.27x | $-19.90 Million | $8.75 Million | ▼ -84.9% |
| 2010 | -1.23x | $-10.70 Million | $8.71 Million | ▼ -236.4% |
| 2009 | -0.37x | $-13.73 Million | $37.57 Million | ▲ +93.4% |
| 2008 | -5.55x | $-64.87 Million | $11.69 Million | ▼ -108.7% |
| 2007 | -2.66x | $-54.93 Million | $20.65 Million | ▼ -43.8% |
| 2006 | -1.85x | $-41.42 Million | $22.39 Million | ▼ -111.3% |
| 2005 | -0.88x | $-20.26 Million | $23.13 Million | ▲ +59.0% |
| 2004 | -2.14x | $-20.69 Million | $9.68 Million | ▼ -1736.3% |
| 2003 | -0.12x | $-9.82 Million | $84.36 Million | ▲ +29.4% |
| 2002 | -0.16x | $-9.24 Million | $56.11 Million | — |